2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92543°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Á¤ºÎ±â°ü¡¤±â¾÷¡¤Çб³ µî Á÷Àå¾î¸°ÀÌÁý ¼³Ä¡ Áõ°¡ (2015-04-30)
»ìÃæÁ¦ ºÐÇØÇÏ´Â ½ÅÁ¾ ¹Ì»ý¹° ¹ß°ß (2015-03-31)
ÇÁ¸®¹Ì¾ö µðÀÚÀÎ Ä¿³Î À̾îÆù F&D E620 (2015-01-30)
Çѱ¹ºø¹°Çùȸ-KTR, ¾÷¹« Çù¾à (2021-05-19)
New ESG Technical Review Highlights Unique ExaGrid Tiered Ba... (2022-01-25)
½Ö¿ëÂ÷, À¯¶ó½Ã¾Æ ´ë·ú Ⱦ´Ü ±â³ä À̺¥Æ® ½Ç½Ã (2017-10-12)
¼¼»ó¿¡¼­ °¡Àå ¸ÚÁø ·¹ÀÌ (2014-10-26)
Ä®¸®¾Æ, Â÷·®¿ë Çìµå·¹½ºÆ® °ÅÄ¡´ë CF-400 (2019-11-04)
¿ì¸®ÀºÇà, ¿øÈ­ ÈļøÀ§Ã¤±Ç 4000¾ï¿ø ¹ßÇà ¼º°ø (2023-06-11)
¸£³ë»ï¼º SM3 Èĺιݻç±â ¸®ÄÝ (2014-10-02)
10¿ù ½Å¼³¹ýÀÎ 7929°³¡¦Àü³âµ¿¿ù´ëºñ0.9% Áõ°¡ (2016-11-29)
ÀÛ»çÀÇ Àü¼³ Áö¿¹, ¡®ÀÓ¹éõÀÇ ¶óµð¿À7080¡¯ Ã⿬ (2016-02-22)
2015 »ó¹Ý±â ¸éÁ¢, ³­À̵µ´Â ñé, ºÐÀ§±â´Â È­±â¾Ö¾Ö (2015-05-29)
ÁÖ¿ªÀÇ º»¶æ, ÁÖ¿ªº»ÀÇ»ó°æÇØ (2014-08-09)
ÀϺ» Á¦Á¶¾÷ Çõ½Å ºÎÁøÀÇ ±³ÈÆ (2015-02-10)
ÁÖ¸ñ¹Þ´Â ½ºÅ¸Æ®¾÷ ¸ðÀÌ´Â ¡®½ºÅ¸Æ®¾÷ 815¡¯ (2022-08-04)
¸ðµÎÀÇ ÁÖ¹æ, ÀÇÁ¤ºÎ 9È£Á¡ ¿ÀÇ (2020-04-07)
CJÁ¦ÀÏÁ¦´ç, Á÷ÀåÀÎ À§ÇÑ BYO ÀåÀ¯»ê±Õ ½ÅÁ¦Ç° (2017-03-16)
2021³â ¼­¿ï¾ÆÆÄÆ®, ÓÞÆø¶ôÀÌ ½ÃÀ۵ȴ٠(2021-01-07)
KT DS ÆÄÆ®³Ê½º µ¥ÀÌ °³ÃÖ ¡®»ó»ýÇù·Â, µ¿¹Ý¼ºÀå ¾à¼Ó¡¯ (2015-07-21)
°³Çå³íÀÇ, ÇÊ¿äÇÏÁö¸¸ ¿©·Ð ¼ö·Å Áß¿ä 56.2% (2013-02-16)
LGÀüÀÚ Àεµ¹ýÀÎ ±¤°í ¡®1¾ïºä¡¯ (2017-10-17)
'ã¾Æ°¡´Â °øµ¿ÁÖÅà °ü¸®µµ¿ì¹Ì¡¯ ¹«·á ¼­ºñ½º ½ÃÇà (2015-05-22)
»ê¿ïÃÊ¡¤»ê¿ïÁß ¿ø¾È ÃßÁø Ã˱¸ ÃÐºÒ Áýȸ (2022-06-17)
BH¿£ÅÍÅ×ÀÎ¸ÕÆ®, ¡®µå¶ó¸¶¿ùµå¡¯ ½ÃÁð2 Âü¿© (2018-07-07)
       [ÀÌÀü][1]....[1724][1725][1726][1727][1728][1729][1730][1731][1732]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..